All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BH-30643Phase 21 trial

    BlossomHill Therapeutics · NSCLC (Advanced Non-small Cell Lung Cancer)

  • BHB810Phase 21 trial

    BigHat Biosciences, Inc. · Gastric Cancer, Gastric Adenocarcinoma, Gastric (Stomach) Cancer

  • BHV-1510PBI-410, GQ1010Phase 21 trial

    Biohaven Therapeutics Ltd. · Solid Tumor

  • BI 754111Phase 21 trial

    Boehringer Ingelheim · Neoplasm Metastasis, Advanced Tumors, Metastatic Solid Tumors

  • BI 836880Phase 21 trial

    Boehringer Ingelheim · Neoplasm Metastasis, Advanced Tumors, Metastatic Solid Tumors

  • BI-1607Phase 21 trial

    BioInvent International AB · Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated

  • BI-1808Phase 21 trial

    BioInvent International AB · Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma

  • BI-1910Phase 21 trial

    BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma

  • BIO-106Phase 21 trial

    BiOneCure Therapeutics Inc. · Advanced Cancer, Advanced Solid Tumor, Cancer

  • BioTTT001Phase 21 trial

    Beijing Bio-Targeting Therapeutics Technology Co., Ltd · Recurrent High-grade Glioma

  • BL0020Phase 21 trial

    Shanghai Best-Link Bioscience, LLC · Small Cell Carcinoma of Lung

  • BL0175Phase 21 trial

    Shanghai Best-Link Bioscience, LLC · Breast Cancer (Locally Advanced or Metastatic)

  • BLU-924SAR449336Phase 21 trial

    Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms

  • BMS-986012Phase 21 trial

    Bristol Myers Squibb · Extensive-stage Small Cell Lung Cancer

  • BMS-986213Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Tumors

  • BMS-986449Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Tumors

  • BMS-986482Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Tumors

  • BMS-986490Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Tumors

  • BMS-986517Phase 21 trial

    Bristol Myers Squibb · Solid Tumours

  • BMS-986523Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • BMS-986525Phase 21 trial

    Bristol Myers Squibb · Relapsed/Refractory Small Cell Lung Cancer

  • BMX-001Phase 21 trial

    BioMimetix JV, LLC · Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm

  • BNT116Phase 21 trial

    Regeneron · Advanced Non-Small Cell Lung Cancer

  • BNT314Phase 21 trial

    BioNTech SE · Metastatic Colorectal Cancer

  • BNT3210Phase 21 trial

    BioNTech SE · Advanced Solid Tumors

  • BNT3212Phase 21 trial

    BioNTech SE · Advanced Solid Tumor

  • BNT3214PM8102Phase 21 trial

    BioNTech SE · Advanced Solid Tumor Cancer

  • BNT329Phase 21 trial

    BioNTech SE · Advanced Solid Cancers

  • BO-112Phase 21 trial

    Highlight Therapeutics · Basal Cell Carcinoma

  • BPI-361175Phase 21 trial

    Xcovery Holdings, Inc. · Non-small Cell Lung Carcinoma

  • BPI-572270Phase 21 trial

    Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)

  • BPM31510Phase 21 trial

    BPGbio · Glioblastoma, Glioblastoma Multiforme

  • BPR-6023021Phase 21 trial

    Chengdu Syncor Pharmaceutical Co., Ltd. · Metastatic Solid Tumors

  • BS006Phase 21 trial

    Binhui Biopharmaceutical Co., Ltd. · Solid Tumor

  • BXQ-350SapC-DOPSPhase 21 trial

    Bexion Pharmaceuticals, Inc. · Metastatic Colorectal Carcinoma, Neuropathy

  • C019199Phase 21 trial

    Fujian Haixi Pharmaceuticals Co., Ltd. · Solid Tumor

  • CAN016Phase 21 trial

    Canwell Biotech Limited · Patients With Advanced Solid Tumors

  • CasdozokitugCHS-388Phase 21 trial

    Coherus Oncology, Inc. · Hepatocellular Carcinoma

  • CBX-12Phase 21 trial

    Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma

  • CC-38Phase 21 trial

    CuraCell TX AB · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced

  • CEB-01Phase 21 trial

    CEBIOTEX · Locally Resectable Pediatrics Tumors

  • certepetideCEND-1, LSTA1Phase 21 trial

    Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma

  • CFI-402257Phase 21 trial

    Treadwell Therapeutics, Inc · Advanced Solid Tumor, Breast Cancer

  • CGT4859Phase 21 trial

    Cogent Biosciences, Inc. · Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult

  • CJRB-101Phase 21 trial

    CJ Bioscience, Inc. · NSCLC, HNSCC, Melanoma

  • CKD-703Phase 21 trial

    Chong Kun Dang Pharmaceutical · Advanced Solid Tumors, Non-Small Cell Lung Cancer

  • CLIO-8221Phase 21 trial

    Callio Therapeutics · Advanced Solid Tumor

  • CM518D1Phase 21 trial

    Keymed Biosciences Co.Ltd · Advanced Solid Tumors

  • CM529D1Phase 21 trial

    Keymed Biosciences Co.Ltd · Advanced Solid Tumors

  • Merck & Co. · Small Cell Lung Carcinoma

NewerPage 16 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.